Cargando…
Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I
Rasmussen syndrome is an intractable epilepsy with a putative causal relation with cellular and humoral autoimmunity. Almost half of the patients have some preceding causative factors, with infections found in 38.2%, vaccinations in 5.9% and head trauma in 8.9% of Japanese patients. In a patient wit...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270760/ https://www.ncbi.nlm.nih.gov/pubmed/17162382 http://dx.doi.org/10.1080/17402520600589522 |
_version_ | 1782151756309856256 |
---|---|
author | Takahashi, Yukitoshi Matsuda, Kazumi Kubota, Yuko Shimomura, Jiro Yamasaki, Etsuko Kudo, Tatsuya Fukushima, Katsuyuki Osaka, Hitoshi Akasaka, Noriyuki Imamura, Atsushi Yamada, Shinji Kondo, Naomi Fujiwara, Tateki |
author_facet | Takahashi, Yukitoshi Matsuda, Kazumi Kubota, Yuko Shimomura, Jiro Yamasaki, Etsuko Kudo, Tatsuya Fukushima, Katsuyuki Osaka, Hitoshi Akasaka, Noriyuki Imamura, Atsushi Yamada, Shinji Kondo, Naomi Fujiwara, Tateki |
author_sort | Takahashi, Yukitoshi |
collection | PubMed |
description | Rasmussen syndrome is an intractable epilepsy with a putative causal relation with cellular and humoral autoimmunity. Almost half of the patients have some preceding causative factors, with infections found in 38.2%, vaccinations in 5.9% and head trauma in 8.9% of Japanese patients. In a patient with seizure onset after influenza A infections, cross-reaction of the patient's lymphocytes with GluRε2 and influenza vaccine components was demonstrated by lymphocyte stimulation test. Database analyses revealed that influenza A virus hemagglutinin and GluRε2 molecules contain peptides with the patient's HLA class I binding motif (HLA − A*0201). The relative risks of HLA class I genotypes for Rasmussen syndrome are 6.1 (A*2402), 6.4 (A*0201), 6.3 (A*2601) and 11.4 (B*4601). The relative risks of HLA class I-A and B haplotypes are infinity (A*2601+B*5401), 21.1 (A*2402+B*1501), 13.3 (A*2402+B*4801) and 5.1 (A*2402+B*5201). Some alleles and haplotypes of HLA class I may be the risk factors in Japanese patients. Cross-reactivity of cytotoxic T lymphocytes may contribute to the processes leading from infection to the involvement of CNS. |
format | Text |
id | pubmed-2270760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-22707602008-03-31 Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I Takahashi, Yukitoshi Matsuda, Kazumi Kubota, Yuko Shimomura, Jiro Yamasaki, Etsuko Kudo, Tatsuya Fukushima, Katsuyuki Osaka, Hitoshi Akasaka, Noriyuki Imamura, Atsushi Yamada, Shinji Kondo, Naomi Fujiwara, Tateki Clin Dev Immunol Research Article Rasmussen syndrome is an intractable epilepsy with a putative causal relation with cellular and humoral autoimmunity. Almost half of the patients have some preceding causative factors, with infections found in 38.2%, vaccinations in 5.9% and head trauma in 8.9% of Japanese patients. In a patient with seizure onset after influenza A infections, cross-reaction of the patient's lymphocytes with GluRε2 and influenza vaccine components was demonstrated by lymphocyte stimulation test. Database analyses revealed that influenza A virus hemagglutinin and GluRε2 molecules contain peptides with the patient's HLA class I binding motif (HLA − A*0201). The relative risks of HLA class I genotypes for Rasmussen syndrome are 6.1 (A*2402), 6.4 (A*0201), 6.3 (A*2601) and 11.4 (B*4601). The relative risks of HLA class I-A and B haplotypes are infinity (A*2601+B*5401), 21.1 (A*2402+B*1501), 13.3 (A*2402+B*4801) and 5.1 (A*2402+B*5201). Some alleles and haplotypes of HLA class I may be the risk factors in Japanese patients. Cross-reactivity of cytotoxic T lymphocytes may contribute to the processes leading from infection to the involvement of CNS. Hindawi Publishing Corporation 2006 /pmc/articles/PMC2270760/ /pubmed/17162382 http://dx.doi.org/10.1080/17402520600589522 Text en Copyright © 2006 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Takahashi, Yukitoshi Matsuda, Kazumi Kubota, Yuko Shimomura, Jiro Yamasaki, Etsuko Kudo, Tatsuya Fukushima, Katsuyuki Osaka, Hitoshi Akasaka, Noriyuki Imamura, Atsushi Yamada, Shinji Kondo, Naomi Fujiwara, Tateki Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I |
title | Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I |
title_full | Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I |
title_fullStr | Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I |
title_full_unstemmed | Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I |
title_short | Vaccination and Infection as Causative Factors in Japanese Patients With Rasmussen Syndrome: Molecular Mimicry and HLA Class I |
title_sort | vaccination and infection as causative factors in japanese patients with rasmussen syndrome: molecular mimicry and hla class i |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270760/ https://www.ncbi.nlm.nih.gov/pubmed/17162382 http://dx.doi.org/10.1080/17402520600589522 |
work_keys_str_mv | AT takahashiyukitoshi vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT matsudakazumi vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT kubotayuko vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT shimomurajiro vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT yamasakietsuko vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT kudotatsuya vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT fukushimakatsuyuki vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT osakahitoshi vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT akasakanoriyuki vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT imamuraatsushi vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT yamadashinji vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT kondonaomi vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi AT fujiwaratateki vaccinationandinfectionascausativefactorsinjapanesepatientswithrasmussensyndromemolecularmimicryandhlaclassi |